Cite

HARVARD Citation

    Shi, Z. et al. (2022). Association of germline rare pathogenic mutations in guideline‐recommended genes with prostate cancer progression: A meta‐analysis. Prostate. 82 (1), pp. 107-119. [Online]. 
  
Back to record